ID   MS1 GNAQ Q209L
AC   CVCL_D4Z6
DR   ATCC; CRL-3530
DR   Wikidata; Q127382889
RX   PubMed=35053574;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4390; GNAQ (Note=With p.Gln209Leu).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; SV40 large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58-3).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6502 ! Mile Sven 1
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
RX   PubMed=35053574; DOI=10.3390/cancers14020413; PMCID=PMC8773683;
RA   Sasaki M., Jung Y., North P.E., Elsey J., Choate K., Toussaint M.A.,
RA   Huang C., Radi R., Perricone A.J., Corces V.G., Arbiser J.L.;
RT   "Introduction of mutant GNAQ into endothelial cells induces a vascular
RT   malformation phenotype with therapeutic response to imatinib.";
RL   Cancers (Basel) 14:413.1-413.11(2022).
//